DeLong Michael R, Tandon Vickram J, Rudkin George H, Da Lio Andrew L
From the *Division of Plastic and Reconstructive Surgery, Department of Surgery, University of California-Los Angeles Medical Center, Los Angeles, CA; and †Section of Plastic and Reconstructive Surgery, Department of Surgery, University of Michigan Medical Center, Ann Arbor, MI.
Ann Plast Surg. 2017 May;78(5 Suppl 4):S185-S188. doi: 10.1097/SAP.0000000000001079.
The latissimus dorsi (LD) myocutaneous flap has been a long term standard for breast reconstruction. The variable indications for the LD flap have not been statistically examined because of the relative infrequency of its use by any single surgeon or institution.
The Nationwide Inpatient Sample data set was queried for all patient encounters involving a LD myocutaneous flap procedure. The study population was further restricted to female patients with a history of breast cancer or previous mastectomy. Demographics, Charlson Comorbidity Index scores, previous radiation history, and additional simultaneous procedures were extracted. Analysis was performed using nonparametric correlation coefficients and linear regression models.
In total, 2304 LD breast reconstruction hospitalizations were identified between 2008 and 2010. Average patient age was 52.1 years, average hospital length of stay (LOS) was 2.8 days, bilateral latissimus reconstruction was performed in 252 (10.9%) patients, and 1414 patients (61.4%) were delayed reconstruction. Previous irradiation was present in 389 (16.9%) patients and was correlated with delayed reconstruction (P < 0.001).Younger age was associated with bilateral latissimus reconstructions (P < 0.05), contralateral free flap reconstruction (P < 0.0001), and combination with implants or tissue expanders (both P < 0.0001).After adjustment for age and Charlson Comorbidity Index, increased LOS was observed in patients undergoing contralateral free flap reconstruction (+1.29 days, P < 0.05) and immediate reconstruction (mastectomy, +0.39 days unilateral, P < 0.05; +0.64 days, bilateral, P < 0.001). The use of tissue expanders and implants were found to decrease hospital LOS (bilateral implant, -0.65 days, P < 0.001; bilateral expander, -0.72 days, P < 0.001), likely from confounding comorbidities. Charlson Comorbidity Index was strongly related to LOS (+0.08 days per point, P < 0.005), whereas age was not statistically significant when considered with comorbidity.
The LD is most commonly used for delayed or salvage breast reconstruction, with particular utility in irradiated patients. Younger patients tend to undergo more involved LD variants with bilateral reconstructions and expanders or implants. After adjusting for comorbidity, age and the use of bilateral latissimus flaps with implants or expanders have no adverse impact on LOS.
背阔肌(LD)肌皮瓣一直是乳房重建的长期标准术式。由于任何单一外科医生或机构使用该皮瓣的频率相对较低,因此尚未对LD皮瓣的各种适应证进行统计学研究。
查询全国住院患者样本数据集,以获取所有涉及LD肌皮瓣手术的患者病例。研究人群进一步限定为有乳腺癌病史或既往接受过乳房切除术的女性患者。提取人口统计学数据、查尔森合并症指数评分、既往放疗史以及其他同期手术信息。使用非参数相关系数和线性回归模型进行分析。
2008年至2010年间共确定了2304例LD乳房重建住院病例。患者平均年龄为52.1岁,平均住院时间(LOS)为2.8天,252例(10.9%)患者进行了双侧背阔肌重建,1414例(61.4%)患者为延迟重建。389例(16.9%)患者有既往放疗史,并与延迟重建相关(P<0.001)。年轻患者与双侧背阔肌重建(P<0.05)、对侧游离皮瓣重建(P<0.0001)以及与植入物或组织扩张器联合使用(两者均P<0.0001)有关。在调整年龄和查尔森合并症指数后,对侧游离皮瓣重建患者(增加1.29天,P<0.05)和即刻重建患者(乳房切除术,单侧增加0.39天,P<0.05;双侧增加0.64天,P<0.001)的住院时间延长。发现使用组织扩张器和植入物可缩短住院时间(双侧植入物,-0.65天,P<0.001;双侧扩张器,-0.72天,P<0.001),这可能是由于混杂的合并症所致。查尔森合并症指数与住院时间密切相关(每增加1分增加0.08天,P<0.005),而在考虑合并症时年龄无统计学意义。
LD最常用于延迟或挽救性乳房重建,在接受过放疗的患者中具有特殊用途。年轻患者倾向于接受更复杂的LD术式,包括双侧重建以及使用扩张器或植入物。在调整合并症后,年龄以及使用双侧背阔肌皮瓣联合植入物或扩张器对住院时间无不利影响。